文献速递关节外科

头孢唑林与全髋关节置换术后假体周围关节感染风险低于替代抗生素方案相关

Cefazolin Is Associated With a Lower Periprosthetic Joint Infection Risk than Alternative Antibiotic Regimens Following Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-05-06

该研究利用2016至2022年全国代表性多支付方数据库,纳入289,369例初次全髋关节置换术患者,比较头孢唑林与替代抗生素预防的90天假体周围关节感染(PJI)风险。结果显示,单用头孢唑林组和头孢唑林联合其他抗生素组的90天PJI风险均低于非头孢唑林组,校正后OR分别为0.62和0.64。

要点

  • 单用头孢唑林组90天PJI率为0.5%,低于非头孢唑林组的0.9%(P<0.001)。
  • 头孢唑林联合其他抗生素组90天PJI率也为0.5%,低于非头孢唑林组的0.9%(P<0.001)。
  • 校正混杂因素后,单用头孢唑林(OR 0.62)和头孢唑林联合其他抗生素(OR 0.64)均与90天PJI风险降低相关。

核心结论

  • 在初次全髋关节置换术中,接受头孢唑林抗生素预防的患者90天PJI率低于接受替代抗生素的患者。

研究设计与样本

  • 研究查询2016至2022年医疗保健数据集,使用当前操作术语和ICD-10操作编码(27130、0SR90xx、0SRB0xx)及骨关节炎诊断(ICD-CM:M16)识别初次全髋关节置换术。
  • 共纳入289,369例初次全髋关节置换术患者,其中25,164例(8.7%)接受非头孢唑林抗生素,200,367例(69.2%)单用头孢唑林,63,838例(22.1%)接受头孢唑林联合另一种抗生素。
  • PJI定义采用医疗保险和医疗补助服务中心手术特定并发症指标中的ICD-10诊断编码,指术后90天内发生的PJI。
  • 采用多项逻辑回归评估头孢唑林使用与PJI的关联,校正年龄、性别、支付方、种族、民族和Elixhauser合并症指数。

主要发现

  • 单因素分析中,非头孢唑林组、单用头孢唑林组和头孢唑林联合其他抗生素组的90天PJI率分别为0.9%、0.5%和0.5%,差异有统计学意义(P<0.001)。
  • 校正年龄、性别、支付方、种族、民族和Elixhauser合并症指数后,单用头孢唑林与90天PJI风险降低相关(OR 0.62,95%CI 0.53-0.72,P<0.001)。
  • 校正后,头孢唑林联合其他抗生素也与90天PJI风险降低相关(OR 0.64,95%CI 0.54-0.76,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There have been conflicting reports on the risk of periprosthetic joint infection (PJI) with the use of alternative antibiotics to cefazolin following arthroplasty. We leveraged recent data from a nationally representative multipayer dataset to investigate this question. METHODS: We queried a health care dataset from 2016 to 2022 to identify primary total hip arthroplasties (THAs) using Current Procedural Terminology and International Classification of Disease (ICD)-Procedure Coding System codes (27130, 0SR90xx, 0SRB0xx) with a corresponding osteoarthritis diagnosis (ICD-Clinical Modification: M16). Patient demographics, characteristics, and outcomes were extracted from existing dataset variables. The PJIs were defined using ICD-10 diagnosis codes from the Centers for Medicare and Medicaid Services' procedure-specific complication measure within 90 days of surgery. We compared PJI between patients receiving cefazolin antibiotic prophylaxis and patients who received an alternative antibiotic or cefazolin plus another antibiotic. The association between cefazolin use and PJI was evaluated using multinomial logistic regression. This study included 289,369 primary THA patients from 2016 to 2022. There were 25,164 patients (8.7%) who received a non-cefazolin antibiotic, 200,367 (69.2%) received cefazolin only, and 63,838 (22.1%) received cefazolin plus an alternative antibiotic. RESULTS: In univariate analysis, there was a significant difference in the rate of 90-day PJI between the non-cefazolin group, cefazolin only, and cefazolin plus other antibiotic group (0.9, 0.5, and 0.5%, respectively, P < 0.001). In a logistic regression analysis that adjusted for age, sex, payer, race, ethnicity, and Elixhauser Comorbidity Index, the use of cefazolin only and cefazolin plus other antibiotic were associated with reduced risk of 90-day PJI (odds ratio 0.62, 95% confidence interval [0.53 to 0.72], P < 0.001) and (odds ratio 0.64, 95% confidence interval [0.54 to 0.76], P < 0.001). CONCLUSIONS: In this nationally representative multipayer study using recent data, patients who received antibiotic prophylaxis with cefazolin had lower 90-day rates of PJI compared to those receiving alternative antibiotics during primary THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Carter BJ, Rumalla KC, Sontag-Milobsky IL, et al. Cefazolin Is Associated With a Lower Periprosthetic Joint Infection Risk than Alternative Antibiotic Regimens Following Total Hip Arthroplasty. J Arthroplasty. 2025. PMID: 40339928. doi:10.1016/j.arth.2025.04.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。